Opportunity ID: 345848

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DK-22-511
Funding Opportunity Title: Limited Competition for the Continuation of the Rare and Atypical Diabetes NeTwork (RADIANT) Specialized Study Centers (U54 – Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Food and Nutrition
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.847 — Diabetes, Digestive, and Kidney Diseases Extramural Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Feb 07, 2023
Last Updated Date: Feb 07, 2023
Original Closing Date for Applications: Jun 07, 2023
Current Closing Date for Applications: Jun 07, 2023
Archive Date: Jul 13, 2023
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following:
Eligible Agencies of the Federal Government; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.

Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: This Funding Opportunity Announcement (FOA) invites applications from the two previously funded Rare and Atypical DIAbetes NeTwork (RADIANT) research centers to further study rare and atypical forms of diabetes mellitus. These centers will continue to identify and analyze phenotypic and genotypic defects that may provide insights into more common, heterogeneous forms of diabetes mellitus in the general population. RADIANT will also continue to develop community resources to advance research in this area through the collection and dissemination of data and samples for access by the broad research community. During this grant cycle, RADIANT will establish precision diagnoses for new Mendelian forms of diabetes by enrolling family members of previously enrolled participants with a family history suggestive of a Mendelian form of diabetes to aid in identifying potential causal variants. In addition, in vitro and basic studies leveraging induced pleuripotent stem cells (iPSCs) differentiated into tissues of interest will be used to establish pathogenicity of potential causal variants.
Link to Additional Information: https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-22-511.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH Grants Information
grantsinfo@nih.gov
Email:grantsinfo@nih.gov

Version History

Version Modification Description Updated Date

Folder 345848 Full Announcement-RFA-DK-22-511 -> RFA-DK-22-511-Full-Announcement.pdf

Packages

Agency Contact Information: NIH Grants Information
grantsinfo@nih.gov
Email: grantsinfo@nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-H Use for due dates on or after January 25, 2023 PKG00279723 May 07, 2023 Jun 07, 2023 View

Package 1

Mandatory forms

345848 RR_SF424_5_0-5.0.pdf

345848 PHS398_CoverPageSupplement_5_0-5.0.pdf

345848 RR_OtherProjectInfo_1_4-1.4.pdf

345848 PerformanceSite_4_0-4.0.pdf

345848 RR_KeyPersonExpanded_4_0-4.0.pdf

345848 PHS398_ResearchPlan_5_0-5.0.pdf

345848 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

345848 PHS_Additional_IndirectCosts_2_0-2.0.pdf

345848 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-10T06:18:23-05:00

Share This Post, Choose Your Platform!

About the Author: